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METHODOLOGY Open Access
Evaluation of a method to measure HHV-6B
infection in vitro based on cell size
Aniuska Becerra-Artiles1, Tessa Santoro1 and Lawrence J. Stern2*
Abstract
Background: Human herpesvirus 6 (HHV-6A and HHV-6B) infection of cell cultures can be measured by different
methods, including immunofluorescence microscopy, flow cytometry, or quantification of virus DNA by qPCR. These
methods are reliable and sensitive but require long processing times and can be costly. Another method used in
the field relies on the identification of enlarged cells in the culture; this method requires little sample processing
and is relatively fast. However, visual inspection of cell cultures can be subjective and it can be difficult to establish
clear criteria to decide if a cell is enlarged. To overcome these issues, we explored a method to monitor HHV-6B
infections based on the systematic and objective measurement of the size of cells using an imaging-based automated
cell counter.
Results: The size of cells in non-infected and HHV-6B-infected cultures was measured at different times post-infection.
The relatively narrow size distribution observed for non-infected cultures contrasted with the broader distributions
observed in infected cultures. The average size of cultures shifted towards higher values after infection, and the
differences were significant for cultures infected with relatively high doses of virus and/or screened at longer times
post-infection. Correlation analysis showed that the trend observed for average size was similar to the trend observed
for two other methods to measure infection: amount of virus DNA in supernatant and the percentage of cells
expressing a viral antigen. In order to determine the performance of the size-based method in differentiating
non-infected and infected cells, receiver operating characteristic (ROC) curves were used to analyze the data.
Analysis using size of individual cells showed a moderate performance in detecting infected cells (area under the
curve (AUC) ~ 0.80-0.87), while analysis using the average size of cells showed a very good performance in detecting
infected cultures (AUC ~ 0.99).
Conclusions: The size-based method proved to be useful in monitoring HHV-6B infections for cultures where a
substantial fraction of cells were infected and when monitored at longer times post-infection, with the advantage
of being relatively fast and easy. It is a convenient method for monitoring virus production in-vitro and bulk infection
of cells.
Keywords: HHV-6B, Cytopathic effect, Cell size, Imaging-based automated cell counter
Background
Since the discovery of the human herpesvirus 6A (HHV-
6A) and HHV-6B, a characteristic cytopathic effect in-
duced in cells has been described. For instance, infected
cells are characterized by the occurrence of enlarged
cells, first described as “balloon-like” syncytia [1]. Presence
of balloon-like cells has often been used as an indicator of
HHV-6 infection of primary cells cultures, ex-vivo infec-
tion of primary cells, and in-vitro infection of various cell
lines [1–4]. However, visual inspection of cell cultures is
subjective and it can be difficult to establish clear criteria
to decide if a cell is infected. Quantitative or semi-
quantitative methods widely used to determine HHV-6 in-
fection include immunofluorescence microscopy (IFA),
flow cytometry, and molecular methods. In IFA, anti-
bodies specific for HHV-6 proteins allow the identification
of infected cells; this method has been used since early
days of HHV-6 research [2, 3]. HHV-6 antisera or mono-
clonal antibodies to various virus proteins have been used,
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including antibodies recognizing glycoproteins B (gB), gH,
gQ, and protein U27 among others [5–8]. A shortcoming
of this method is that it requires a lengthy sample process-
ing with multiple incubation and washing steps, as well as
the scanning of randomized fields in an adequate micro-
scope to obtain a representative sample adequate for
quantitative analysis. In addition, IFA-based methods are
subjected to person-to-person variability in the read-out,
often requiring readings by two or more experienced in-
vestigators. An alternative is the analysis of cells stained
with the fluorescent-labeled antibodies by flow cytometry
[9–11]. This method circumvents the subjectivity of the
microscopy methods, although still requires multiple in-
cubations and washing steps and adequate instrumenta-
tion. Molecular methods to detect HHV-6 infection
include detection of expression of viral genes by reverse-
transcription PCR [11–13] and measurement of the
amount of viral genome in infected cells or cell culture
supernatants by quantitative PCR. Quantitative-PCR
(qPCR)-based methods are very sensitive and are widely
used [14–18]. However, they require specialized equip-
ment, reagents, and sample processing, and do not pro-
vide information about the actual number or frequency
of infected cells or the amount of infectious virus pro-
duced, and so represent only an indirect measure of the
infection.
The search of a fast and simple method to objectively
monitor HHV-6 infection in-vitro on a daily basis led us
to explore the use of an imaging-based automated cell
counter able to measure the size of cells in a cell suspen-
sion. Measurements of the average size of cells (usually
as cell diameter) using automated cell counters have
been used for some time to monitor infections, in par-
ticular in cell culture systems set up for recombinant
protein production using insect cells. For example, infec-
tion of Sf-9 cells with Baculovirus expression vectors re-
sults in changes in average size during the progress of
infection, and monitoring the average size of the cells
has been useful to estimate the degree of infection [19],
to predict the yield of recombinant protein produced
[20], and also to estimate virus titers [21]. The work pre-
sented in this paper consists of a series of analyses that
explore the feasibility of using a cell counter to routinely
monitor HHV-6B infections in SupT1 cells. Results sug-
gest that this method is fairly reliable to estimate infec-
tions when high doses of virus and/or long times are
used; when compared to other methods like IFA, flow
cytometry and qPCR, it is faster and simpler.
Methods
Virus
HHV-6B strain Z29 was provided by S. Jacobson
(NINDS, Bethesda, MD). Virus stocks were produced in-
fecting the human T lymphoblast cell line SupT1 (CRL-
1942™, American Type Culture Collection, Manassas,
VA) for 7 days as described below. At this time, cultures
were collected, spun at 756 x g for 7 min, and super-
natant kept in aliquots frozen at −80 °C until use. For
each virus stock, the amount of protected HHV-6B
DNA per mL of supernatant was measured by qPCR as
described below; protected DNA is not sensitive to di-
gestion by treatment with DNase-I prior to purification.
The values obtained (copies DNA/mL) were used as an
indicator of the amount of virus in each stock, and all
infections were done considering this parameter when
the virus stock dose was determined. Virus was purified
from culture supernatant by sequential low-speed centri-
fugation, followed by ultracentrifugation to obtain a con-
centrated extracellular virus [22]. The concentrated
extracellular virus was loaded onto an Optiprep® (Sigma-
Aldrich Inc., St. Louis, MO) step gradient (10-40%) and
centrifuged at 160,000 x g for 90 min. Fractions were
collected from the bottom and the purified virus was re-
covered from the fraction containing the peak of HHV-
6B strain Z29 specific DNA.
Infection assays
Cell lines SupT1 and SupT1.CIITA [23], as well as
MOLT-3 (CRL-1552™) and Jurkat E6 (TIB-152™) (both
American Type Culture Collection, Manassas, VA) were
infected with HHV-6B strain Z29. Cells were collected
during the exponential phase of growth and incubated
with the HHV-6B virus stock. For dose-response experi-
ments, serial dilutions of the virus stocks were used for
infection; for time-course experiments, a single dose of
300 copies of virus DNA per cell was used for infection;
for virus inactivation experiments, live or inactivated
virus, obtained by incubating the virus stock at 56 °C in
a water bath for 1 h or under UV light for 1 h, were
used. For infection, cells were incubated with the live or
inactivated virus stock for 3 h at 37 °C. Cells were then
centrifuged and the virus stock aspirated, followed by 2
washes with phosphate saline buffer pH 7.4 (PBS).
Finally, cells were resuspended in RPMI 1640 medium
supplemented with L-glutamine (2 mM), penicillin
(100 U/mL), streptomycin (100 μg/mL) and 5% fetal bo-
vine serum (FBS) at a density of 0.5 × 106 cells/mL and
transferred to plates or flasks. At this time, baseline sam-
ples (t = 0 dpi) were collected. The remaining samples
were maintained at 37 °C/5% CO2 for the time of infec-
tion. At each time point, cell cultures were inspected
under the optical inverted microscope (NIKON Eclipse
TE2000U equipped with a digital CCD camera) and a
sample of the cell suspension was collected for analysis
in the imaging-based cell counter. The remaining cell
suspension was spun at 756 x g for 7 min, an aliquot of
the supernatant was stored at −80 °C for virus DNA iso-
lation and quantitation, and cells were washed with PBS
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and used for other assays (microscopy, flow cytometry,
RNA isolation). HSB-2 cells (CCL-120.1™, American
Type Culture Collection, Manassas, VA) were infected
by mixing fresh non-infected cells with a cell pellet of
HSB-2 cells infected with HHV-6A strain GS at a ratio
5:1, and cultured in Iscove’s Modified Dulbecco’s
medium supplemented with L-glutamine (2 mM), peni-
cillin (100 U/mL), streptomycin (100 μg/mL) and 5%
fetal bovine serum (FBS) at a density of 0.5 × 106 cells/
mL; cultures were inspected every 3 – 4 days and a sam-
ple of the cell suspension was analyzed in the cell coun-
ter each time.
Size measurements
Cells suspensions were carefully resuspended by pipet-
ting up and down using a serological pipette, and ana-
lyzed using an imaging-based cell counter after mixing
1:1 with 0.2% trypan blue. The Cellometer Bright Field
Cell Counter Auto T4 (Nexcelom Biosciences LLC.,
Lawrence, MA), which uses bright field imaging and
pattern-recognition software to identify and count indi-
vidual cells in 8 different fields of a slide in 20 μl sam-
ples was used to collect the data [24]. For SupT1, large
size cells parameters (set to measure cell sizes between 8
and 50 μm) were used; same parameters were used for
MOLT-3 but adjustments were introduced for mea-
suring SupT1.CIITA (extending the range to 100 μm),
Jurkat E6 and HSB-2 (adjusted to include smaller cells).
These parameters usually guaranteed all cells observed
in the slide were counted. Inspection of the fields before
counting was routinely performed, to ensure absence of
cell clumps (the software also has a de-clumping func-
tion). Raw data obtained consisted in count and size of
each live and dead cell; in addition, cell size distribution,
cell density, and viability (assessed by trypan blue exclu-
sion assay) were reported by the software.
DNA extraction and qPCR
DNA was extracted from frozen supernatants, using the
QIAmp Minielute Virus Spin kit (QIAGEN Inc., Valen-
cia, CA), following manufacturer’s instructions. Prior to
extraction, digestion of un-protected DNA was per-
formed incubating the sample with DNase-I (Roche
Diagnostics Corporation, Indianapolis, IN) for 30 min at
37 °C, followed by addition of EDTA (final 15 mM) and
incubation at 70 °C for 10 min [25]. This step ensures
the quantitation of encapsidated virus only. Real-time
qPCR was used to quantify specific HHV-6B strain Z29
DNA, using forward primer 5′-GAG ACC GGG TCT
GGA CAA CA-3′; reverse primer 5′-GAG TTG CTG
AGT TGG TAA AGG-3′; and probe 6-FAM-CTC CAA
GTG TAC CGA AAC GCT TCC TGG–TAMRA (Ap-
plied Biosystems, Thermo Fisher Scientific, Inc.); this set
of primers and probe amplify a region in the U90 gene.
A calibration curve (< 1 - 107 copies DNA per reaction)
was obtained using serial dilutions of a plasmid contain-
ing the gene amplified by the primer set. Reactions were
carried on CFX96 Real Time System (Bio-Rad Labora-
tories, Inc.). Copies of viral DNA per well were calcu-
lated using the measured Ct values and the calibration
curve. Amplified product was not observed for dilutions
of plasmid containing ≤ 1 copy per well, and we consid-
ered this to be our lower limit of detection. An average
of 8 ± 2 copies per well were reliably detected with 100%
detection rate. Copies of viral DNA amount per mL of
supernatant were calculated using the per well values
and the appropriate dilution factors, yielding a detection
limit of 6 × 103 copies/mL, Ct > 41). In test experiments
we found that two washes were sufficient to remove >
90% of the viral inoculum from infected cultures, with
an additional wash not further reducing residual virus.
Thus for high dose infections, viral DNA in supernatant
could be detected early after infection even in the absence
of viral replication. This level was essentially constant for
measurements at day 0 and day 1, with significant in-
creases (> 30-fold) observed for day 2 and beyond.
Flow cytometry
Monoclonal antibody anti-HHV-6 gp116/64/54 (Clone
6A5G3), recognizing a late antigen (glycoprotein B, gB),
was obtained from the HHV-6 Foundation Reagent Re-
pository. Non-infected and infected SupT1 were stained
at 4 and 7 days post-infection (dpi) with anti-gB (dilu-
tion 1:100) after fixation and permeabilization using the
CytoFix/CytoPerm kit (BD Biosciences, San Jose, CA).
Goat-anti-mouse-IgG (Fab)-FITC (KPL, Inc., Gaithersburg,
MD) or goat-anti-mouse Ig-BV421 (BD Biosciences, San
Jose, CA) were used as secondary antibodies. Unstained
cells and cells stained with isotype control antibody
(IgG2b; BD Biosciences, San Jose, CA) were used as con-
trols. Data were acquired using a BD LRSII flow cytometer
equipped with BD FACSDiva software (BD Biosciences,
San Jose, CA) and analyzed using FlowJo v. 10.1 (FlowJo,
LLC, Ashland, OR). Dead cells and cell debris were gated
out and FITC or BV421 fluorescence was determined in
live, single cells. Gates were set considering live cells and
background fluorescence from non-infected cells stained
with the virus-specific antibodies, from infected cells
stained with isotype control, and from auto-fluorescence of
infected cells.
RNA extraction and RT-PCR
SupT1 non-infected or infected with live or inactivated
HHV-6B strain Z29 were used to verify transcription of
viral genes at 4 and 7 dpi. At the various time points
cells were collected by centrifugation, washed with PBS
and total RNA was extracted using the RNeasy kit (QIA-
GEN Inc., Valencia, CA), following manufacturer’s
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instructions. The procedure included a DNase-I digestion
step, to digest any free virus DNA present in the prepar-
ation. First strand DNA synthesis was performed using
RevertAid First Strand cDNA Synthesis kit (Thermo Sci-
entific, Inc.), starting from ~ 1 μg total RNA. RT-PCR was
performed using Dream Taq Green PCR Master mix
(Thermo Scientific, Inc.) and primers for two virus tran-
scripts (U86 and U12) and beta-actin as reference gene
(all primers sequences from De Bolle et al. [26]).
Electron microscopy
Electron microscopy analysis was performed by the Core
Electron Microscopy Facility (University of Massachusetts
Medical School, Worcester, MA). Infected and non-
infected cells (prepared following directions from the facil-
ity) were analyzed by transmission electron microscopy
(TEM) and scanning electron microscopy (SEM). Virus
purified from supernatant of infected cells was analyzed
by negative staining.
Statistical analysis
Statistical analyses were performed using PRISM v7
(GraphPad Software, Inc.). For comparison among groups
t-test or Mann-Whitney test (2 groups) or ANOVA (3 or
more groups) were used. Pearson product-moment cor-
relation coefficient was used to evaluate linear correl-
ation between variables; linear regression was done
using the least squares fit. Receiver operating character-
istic (ROC) analysis was used to evaluate the perform-
ance of the methods and select cutoff values. Cutoff
values were selected maximizing the product of specifi-
city and sensitivity [27].
Results
Characterization of the cytopathic effect induced by HHV-
6B infection in SupT1 cells
In order to verify that the infection with HHV-6B virus
induced the characteristic cytopathic effect in SupT1
cells, i.e. the occurrence of enlarged cells, cells were in-
fected with HHV-6B strain Z29 at a ratio of 300 copies
DNA per cell and the cultures were monitored daily for
up to 7 days. Figure 1a shows phase-contrast optical mi-
croscopy images of non-infected SupT1 and SupT1 in-
fected with HHV-6B after 1 to 5 days post-infection
(dpi). Enlarged cells can be already observed at 2 dpi,
and the number and size of these cells increased with
time. Cytopathic effect can also be appreciated by flow
cytometry, in forward (FSA) versus side (SSA) scatter
plots. In the example presented in Fig. 1b, increase in
both size (FSA) and granularity (SSA) of infected cells at
4 and 7 dpi is evidenced by a shift of the cells’ distribu-
tion towards higher values. The striking differences in
size can be fully appreciated in Scanning Electron Micros-
copy (SEM) images, where the homogeneous population
of small non-infected cells gives rise to a population con-
taining bigger cells of heterogeneous size, including some
giant cells (Fig. 1c).
To confirm that the presence of enlarged SupT1 cells
was indeed a result of a productive infection and not a
result of the “fusion from without” phenomenon [28],
samples were analyzed for active replication and produc-
tion of virions. Ultra-thin slices of infected cells analyzed
by Transmission Electron Microscopy (TEM) (Fig. 1d)
showed evidence of the production of virions. Capsids
were identified in the nucleus (white arrowhead), and
viral particles at different stages of maturation (black
arrowhead) were observed in the cytoplasm as well as in
the extracellular space (black arrows). Extracellular virus
was present in the supernatant of infected cells, as evi-
denced by negative staining of virus purified from the
cell culture supernatant (Fig. 1e, black arrows); the virus
in these supernatants was infectious, as indicated by
their ability to infect fresh non-infected cells. Moreover,
virus genome replication was verified by detection of in-
creased levels of virus DNA produced (~ 1.5 × 109 cop-
ies/mL in cultures infected with live virus vs. < 5 × 105
copies/mL in cultures infected with inactivated virus).
Further, expression of two viral transcripts (from genes
U86 and U12) was evaluated, confirming that cells in-
fected with live virus expressed high levels of these tran-
scripts (Fig. 1f ), while non-infected cells or cells infected
with inactivated virus showed no or low-levels of expres-
sion of the transcripts. All these results confirm that
SupT1 cells were productively infected by HHV-6B.
Assessment of HHV-6B infection by measuring the size of
cells
Given the occurrence of enlarged cells in cultures of
SupT1 infected with HHV-6B, we investigated whether
the measurement of the size of the cells and the number
of enlarged cells could be used as an indicator of the
level of infection of the culture. One method to measure
the size of cells is using an imaging-based automated cell
counter. In this work, we use a Cellometer Auto T4 in-
strument for bright field image capture and analysis
(Nexcelom Biosciences LLC.). This instrument essen-
tially is a low-resolution imaging microscope that uses
bright field imaging and pattern-recognition software to
identify and count individual cells [24].
In order to assess whether the use of the imaging-
based automated cell counter was suitable to obtain an
objective and accurate measurement of the size of cells
infected by HHV-6B, SupT1 cells infected with different
doses of the virus and followed for up to 7 days were an-
alyzed. The average size of cells in culture and the viabil-
ity were measured daily. For comparison and validation,
HHV-6B infection was also assessed by other methods.
The amount of protected virus DNA in supernatant was
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quantified by qPCR and the percentage of cells express-
ing a viral glycoprotein (gB) was measured by flow cy-
tometry. Results are shown in Figs. 2a-e. The average
size of cells in the infected cultures progressively in-
creased after infection, and the increases in average size
were more marked when higher amounts of virus were
used (Fig. 2a). For low doses of virus, only very slight
changes in average size of the cultures were observed,
which were similar to the slight changes observed in
non-infected cells. In terms of viability of the cultures, a
progressive declined after 3 dpi was observed (Fig. 2b).
Furthermore, quantification of virus DNA in superna-
tants showed a progressive increase with time of virus
DNA accumulated in supernatants for all doses of virus
tested. Higher doses resulted in larger increments of
virus DNA in supernatant compared to the residual
amount at day 0 (> 100-fold at 3 dpi), while lower doses
resulted in smaller increments (Fig. 2c). In addition, both
the percentage of infected cells positive for gB expres-
sion (Fig. 2d), and the median fluorescence intensity
Fig. 1 Cytopathic effect in HHV-6B-infected SupT1. a. Phase-contrast microscopy images (20×) of SupT1 cells suspension non-infected and infected at
different days post-infection (dpi); bar = 100 μm. b. Flow cytometry scatter plots (FSA vs SSA) of non-infected and infected SupT1 cells at 4 and 7 dpi.
C. SEM images (2,000×) of non-infected and infected SupT1 at 4 dpi. Bar: 30 μm. d. TEM images (43,000×) of infected SupT1, showing different stages
of virus replication: nucleocapsids in the nucleus (white arrowheads), tegumented virus acquiring envelope in the cytoplasm (black arrowheads), and
virions in the extracellular space (arrows); bars = 0.2 μm. e. Negative staining (20,500×) of virus purified from supernatant of infected cells; arrows show
virions; bar = 0.5 μm. f. Viral gene expression in SupT1 non-infected or infected with live or inactivated virus (HI = heat-inactivated; UVI = UV-inactivated)
at 4 and 7 dpi. Agarose gel shows PCR products for U86 (top), U12 (middle) and beta-actin (bottom) transcripts for each condition
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(MFI, Fig. 2e), were higher for cultures infected with
higher doses of virus. Expression of gB in cells increased
with time at all doses tested, with the exception of the
highest dose at the last time point for which a decrease
was observed. In general, doses of virus that induced
marked increases in the amount of DNA accumulated in
supernatant and the expression of gB in cells also in-
duced measurable increases of the average size of the
cells in infected cultures.
Figs. 2f-j summarizes the results of infections using
different virus stocks at a single dose of virus (300 cop-
ies of DNA per cell, n = 7-10 independent infections).
Results confirm the trend observed before: the average
size of cultures progressively increased after infection
(Fig. 2f ). Increases were statistically significant at and
after 3 dpi compared to the initial average size. By 3 dpi
the average size increased about ~ 30%; by 7 dpi an
additional 15% increase was observed. From 3 dpi, the
viability of the cells progressively declined, and the de-
crease was significant at and after 5 dpi (Fig. 2g). The
amount of virus DNA released into the supernatant in-
creased more than 100 times from the residual amount
of the virus measured at day 0 during the first 3 days of
infection; then, it reached a plateau, with an additional
increase of ~ 2-3 times by 7 dpi (Fig. 2h). The expres-
sion of gB was increased at both 4 and 7 dpi, however
with a large variability in the measurements (Figs. 2i-j).
The trends were consistent for all virus stocks tested,
with the differences observed possibly related to the ac-
tual infectivity of the different stocks (stocks were used
based on copies of virus DNA/mL, which does not al-
ways correlate with infectivity). Finally, the effect of
virus inactivation prior to infection was tested. When
infection of SupT1 with live virus was compared to in-
fection with heat-inactivated or UV-inactivated virus, a
substantial increase in the average size of the cells was
observed only for the live virus (see Additional file 1),
indicating that a productive infection is indeed ne-
cessary for the occurrence of the enlarged cells in this
system. Overall, these results show that an imaging-
based automated cell counter is able to reveal differ-
ences induced by infection at different doses and times.
Measurements of the average size of cells in infected
cultures follow a similar trend as other methods used
to measure the infection, suggesting that the size mea-
surements can indeed be useful to monitor and
characterize HHV-6B infections.
Size measurements in non-infected and HHV-6B-infected
SupT1 cells
In order to study the ability of the size measurement-
based method to distinguish non-infected and infected
cells and cultures, analysis of three populations of cells
was performed: infected cells at 4 dpi (representing the
a
b
c
d
e
f
g
h
i
j
Fig. 2 Characterization of HHV-6B-infection by different methods.
Time-course of cells infected with different doses of a virus stock,
measured at different times: a. Average diameter of cells (μm); b. Cell
viability (%); c. Virus DNA in supernatant (copies/mL); d. Percentage
of glycoprotein B positive cells (Pct gB+ cells); e. gB median fluorescence
intensity (gB MFI). Summary of time-course experiments of SupT1
infected with different virus stocks at a single dose of virus (300
copies per cell): f. Average size; g. Cell viability; h. Virus DNA in
supernatant; i. Pct gB+ cells; j. gB MFI. Box plots show median,
quartiles, and standard deviation of 7-10 independent infections.
* Day 1 values in panels c and h reflect residual viral DNA present
despite extensive washing. † Limit of detection
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earliest time point where the different indicators of in-
fections reached a maximum); infected cells at 7 dpi
(which is the standard time to collect supernatant during
the production of virus); and non-infected SupT1, usu-
ally collected at 4 days after a new culture was estab-
lished. Data from multiple replicates (independent
infections using different virus stocks) were collected
over months (non-infected n = 36; 4 dpi n = 14; 7 dpi n
= 19). The raw data collected using the imaging-based
cell counter was used to generate size histograms for
each sample (Fig. 3a), and non-linear fits of the raw data
to Gaussian curves were calculated Fig. 3b). These re-
sults showed that non-infected cells comprised a relatively
narrow population in size, that for infected cells a broad
ranges of sizes was observed, and that the overall size pop-
ulations were shifted dramatically upon infection.
In order to compare the three populations, two ap-
proaches were used. In one approach, raw data (size of
each cell) from the different replicates within a popula-
tion were combined and the histograms and fits for the
three populations were obtained (Fig. 3c). When the
populations were compared, a shift toward larger sizes
in infected cells was observed, along with an overlap be-
tween the non-infected and infected populations. In the
other approach, the processed data (average size of cells)
was used. For instance, for each replicate instead of
using the size of individual cells, the average size of all
cells counted in that sample was calculated; then, values
from different replicates within each population were
used for the comparisons (Fig. 3d). The use of the par-
ameter “average size of the cells” resulted in a clear sep-
aration (less overlap) between non-infected and the two
infected cell populations. Statistically significant differ-
ences were found between non-infected and the two in-
fected populations (although not between 4 and 7 dpi
populations).
We explored the feasibility of using average size mea-
surements to evaluate HHV-6 infection in other systems.
We tested the human T lymphoblast cell lines SupT1.-
CIITA, MOLT-3, and Jurkat E6 for infection with HHV-
6B strain Z29, and the human T- lymphoblast cell line
HSB-2 for infection with HHV-6A strain GS. For all com-
binations of cell lines and virus strains tested, a mea-
surable shift in the average size of infected cells compared
to non-infected cells was observed (Additional file 2). The
susceptibility of different cell lines to cytopathic effects
after infection was variable, depending on the combin-
ation of cell line and virus as well as doses of virus and
time post-infection (not shown). Also, the average size of
the non-infected cultures was slightly different for the dif-
ferent cell lines. Interestingly, the cell line SupT1.CIITA
was prone to generate a high proportion of cells larger
a b c
d
Fig. 3 Assessment of HHV-6B infections using size measurements. a. Example of raw data obtained from a single sample of non-infected or infected
cells at 4 and 7 dpi, graphed as a histogram of cell sizes. b. Non-linear fit of the data at 7 dpi for a single replicate (left), and for data from 36 non-
infected, 14 infected at 4 dpi and 19 infected samples (right). c. Histograms and non-linear fit of size data from non-infected (open bars) and infected
(light gray (4 dpi) and dark gray (7 dpi)) cells; multiple replicates within a population were combined. d. Average size of cells for different replicates
within a population (non-infected, 4 and 7 dpi, same color scheme described before); statistical significance levels (ANOVA) are presented
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than the observed in SupT1 (>100 μm), which also ap-
peared at shorter times (2 dpi); the analysis of samples
containing a high proportion of these cells was more com-
plicated and not accurate, as these cells were hard to sam-
ple homogeneously. Overall, it appears that this method
should be applicable to other systems, but optimization
for each case likely would be necessary.
Performance of size measurements in differentiating non-
infected from infected SupT1 cells and cultures
We used ROC (receiver-operating characteristic) analysis
[29] to evaluate the performance of size measurements
as a method to differentiate non-infected and infected
cells and/or cultures. ROC curves show the tradeoff be-
tween sensitivity and specificity. Sensitivity is the ability
to detect a positive response; an assay with high sensitiv-
ity would provide few false negatives. Specificity is the
ability to exclude negative responses; an assay with high
sensitivity would identify few false positives. An ideal
assay provides high specificity and high sensitivity, but
development of a practical assay involves tradeoffs be-
tween these. ROC curves were calculated for both of the
measurements, size of individual cells and average size
of cells in culture, and are shown in Fig. 4a and b for 4
and 7 dpi respectively. We used measurements from
non-infected cells as negative controls and data from in-
fected cells and/or cultures as experimental conditions.
An ROC curve for an ideal assay is a vertical line on the
y-axis (at specificity = 1.0) with a horizontal line at sensi-
tivity = 1.0. A ROC curve for an assay that is not better
than random prediction is a diagonal line. It is apparent
that both measurement approaches have great power in
differentiating non-infected and infected cells or cul-
tures, in particular when the average size (Fig. 4b) was
used.
The area under the ROC curve (AUC) represents the
probability of correctly identifying a positive sample,
specifically the probability that a randomly selected true
positive will have a higher predicted value than a ran-
domly selected true negative. The AUC for an ideal assay
is 1.0 and for a random assay is 0.5. AUC values for both
measurements, individual size and average size, are also
shown in Fig. 4a and b. Measurement of the average size
performance approximates the ideal. For the individual
size measurements, there is a trade-off between specifi-
city and sensitivity, because of the overlap in the size-
distribution profiles (Fig. 4c). A cutoff that includes all
infected cells (gray histogram) will necessarily include
some non-infected cells (dashed histogram). Size distri-
bution profiles for measurements of the average size
(Fig. 4d) overlap to a much lesser degree.
ROC analysis can be used to identify an optimum cut-
off value. In order to optimize the proportion of false
positives and false negatives, we identified a suitable
cutoff value by maximizing the product of sensitivity
and specificity [27]. The cutoff values calculated define
regions in the size distribution plots (shaded area in Fig.
4c and d), which were expected to contain infected cells
or cultures with high confidence. With this cutoff, the
average size was associated with a low overlap between
the populations, which correspond to lower percentages
of misidentifications. On the other hand, size of individ-
ual cells has higher overlap and higher percentage of
misidentifications. The calculated cutoff values, level of
sensitivity and specificity, and the rates of false positives
and negatives are shown in Table 1. For simplicity, con-
sensus values for both approaches were also selected;
the trade-off associated to both sensitivity and specificity
using the consensus values also is reported in Table 1.
We tested this approach in evaluating a large set of ex-
perimental infections used for virus production with dif-
ferent virus stocks performed on different days. The
fraction of enlarged cells was defined using the cutoff
values described above. Fig. 4e shows the percentage of
enlarged cells calculated for non-infected and infected
samples. There is a clear difference in the percentage of
cells above the cutoff between non-infected and infected
samples; Mann-Whitney analysis shows the differences
are statistically significant under these conditions. This
result suggests that this approach could also be used to
differentiate non-infected from infected cultures. A ROC
analysis of this experiment is shown in Additional file 3.
Correlation of size-based method with other methods
In order to validate the method based on size measure-
ments as suitable way to estimate infection, correlation
analysis between size-based method and two other
methods (levels of virus DNA in supernatant and per-
centage of cells expressing gB) was performed. Correl-
ation of average size of cells in culture vs. copies of virus
DNA/mL and vs. percentage of cells expressing gB are
shown in Fig. 5a and b, respectively. Correlation of per-
centage of cells with size above the cutoff vs. copies of
virus DNA/mL and vs. percentage of cells expressing gB
are shown in Fig. 5c and d, respectively. Correlation be-
tween copies of virus DNA/mL and percentage of cells
expressing gB is shown in Fig. 5e. Significant positive
moderate correlations were observed in all cases. Corre-
lations using average size of cells in culture were similar
or better than correlations using percentage of cells with
size above the cutoff. Altogether these results indicate
that all three methods depict a similar trend when used
to estimate the level of infection.
To explore the feasibility of using the percentage of in-
fected cells calculated by the size analysis to predict ac-
tual percentage of cells expressing viral antigens, linear
regression analysis was performed. The coefficient of de-
termination (r2) was 0.51, which indicates that about
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51% of the data on antigen expression can be explained
by the data on percentage of cells with size above the
cutoff values. The standard error of the estimate (Sy.x)
was 20.0%; the error in predicting the percentage of cells
expressing viral antigens was slightly lower than the
standard deviation for the measurements of percentage
of cells positive for the antigen (64.1 ± 27.5); these re-
sults suggest a moderate accuracy of the predictions.
Relative sensitivity range of size-based method
To test the range of sensitivity of the method, cultures
of cells infected with serial dilutions of virus stocks were
monitored at 4 dpi, measuring the average size of the
cells, DNA copies/mL by qPCR, and percentage of cells
expressing gB by flow cytometry. Infecting cells with in-
creasing dilutions of the virus stock resulted in reduction
in the average size of the cells relative to that observed
for the undiluted virus stock (Fig. 6). For the two viral
stocks tested in the experiment shown (s75 in Fig. 6a
and s112 in Fig. 6b) the average cell diameter did not de-
crease for dilutions below 1:50. The average size of cells
for these dilutions was below the cutoff value calculated
at 4 dpi (13.5 μm, broken line in Fig. 6a and b), which
suggests that these samples can be considered as nega-
tive by the size-based method. Figure 6c shows amount
of virus DNA in supernatant for the s75 infection and
Table 1 Sensitivity and specificity for selected cutoff values
Size measurement approach Size of individual cells Average size
Infection day (dpi) 4 7 4 7
Cutoff value (μm)a 13.9 14.3 (13.9) 14.2 (13.5) 13.5
Sensitivityb 0.77 0.66 (0.69) 0.93 (0.96) 1.00
False negativesc 23% 34% (31%) 7% (4%) 0%
Specificityb 0.87 0.91 (0.87) 1.00 (0.96) 0.96
False positivesc 13% 9% (13%) 0% (4%) 4%
aCutoff value for maximized product of sensitivity and specificity for each size
measurement approach and infection day (dpi); in parenthesis, a consensus
cutoff value for each size measurement approach is shown. bSensitivity and
specificity at each cutoff value; in parenthesis, sensitivity and specificity
associated with the consensus cutoff values. cPercentage of false negatives
and false positives at each cutoff values; in parenthesis, values for consensus
cutoff values
a b
c
e
d
Fig. 4 Performance of size measurements as a method to differentiate
non-infected from infected cells and/or cultures. ROC curves obtained
for size of individual cells (a) and for average size of cells (b), using a
non-infected culture as control and infected cultures at 4 or 7 dpi as
experimental conditions. The AUC and significance level are shown in
each case. Non-linear fit for each pair of data analyzed showing
the cutoff selected when the analysis was done using size of individual
cells (c) or average size of cells (d) at 4 or 7 dpi. The shaded area
comprises the range of sizes for infected cells or cultures at the
selected cutoffs. e. Estimation of the percentage of infected cells
derived from the analysis using size of individual cells. Statistical
significance level determined by Mann-Whitney
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Fig. 5 Validation of size measurements. Correlation analysis performed between average size and virus DNA in supernatant (a) or average size
and percentage of gB positive cells (Pct gB+ cells) (b); correlation between percentage of cells above the cutoff size and virus DNA in supernatant (c) or
percentage of cells above the cutoff size and Pct gB+ cells (d); and correlation between Pct gB+ cells and DNA in supernatant (e). Pearson’s correlation
coefficients and statistical significance levels are shown
a b
c d
Fig. 6 Relative sensitivity range of size, qPCR and flow cytometry measurements. a-b. Dilution curve for two virus stocks, using the average size
as a method to measure level of infection (A = s75, B = s112); broken line indicates cutoff value for the size method (13.5 μm). c. Dilution curve of
s75 using qPCR (copies of DNA/mL in supernatant) as measurement of infection. d. Dilution curve of s112 using percentage of gB positive cells
(Pct gB+ cells) as measurement of infection; broken line indicates the cutoff value (4.7%). In all graphs, open symbols indicate dilutions that were
categorized as negative by the size-based method
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Fig. 6d shows percentage of gB in cells for the s112 in-
fection. As observed with the average size, increasing di-
lution resulted in lower copies of DNA/mL in
supernatant and lower percentages of cells expressing
gB. However, for dilutions categorized as negative by the
size-based method (open circles in Fig. 6), changes in
copies of DNA/mL and to a lesser extent expression of
gB could be clearly detected. This indicates a lower sen-
sitivity in the size-based method as compared to the flow
cytometry and qPCR assays.
Measuring infectivity using size-based method
We evaluated whether size-based tissue culture infectious
dose (TCID50) measurements provide an effective tool for
determining the relative infectivity of viral stocks. Infecti-
vity of virus stocks usually is assessed by end-point dilu-
tion assay, which allows the calculation of the TCID50 and
the associated titer, using the method described by Reed
and Muench [30]. The read-outs generally used for deter-
mination of relative infectivity are visual inspection of cul-
tures for identification of enlarged cells; IFA or flow
cytometry to detect expression of viral gene products on
infected cells; or recently, Gustafsson et al. described a
method that uses qPCR measurements as read-out of in-
fection for TCID50 assays [31]. In order to evaluate the
size-based method as a read out for TCID50, an end-point
dilution assay was set up. We infected SupT1 cells with
serial dilutions of viral stocks (4 wells per dilution) meas-
uring the average size of cells in each well at 4 dpi. In-
fected cultures exhibiting average cell size higher than the
cutoff value (13.5 μm) were considered positive infections.
The method was used to estimate the infectious potential
of 12 virus stocks, with values reported as TCID50/mL; the
same stocks were evaluated for copies of viral DNA/mL
using qPCR (Table 2). Next, we used the 12 different
HHV-6B stocks to infect SupT1 cells at various doses of
virus, monitoring infection using average size as well as
qPCR and flow cytometry assays (Fig. 7a). We observed
good correlation between the level of infection measured
by any of the methods and the dose of the various stocks
calculated using the size-based TCID50/mL. We compared
these values to those determined using DNA copies/mL
instead of TCID50/mL as a measure of the dose virus in
the various infections. In contrast to the results using
TCID50 per cell, no significant correlation was observed
between measures of infection and DNA copies per cell
used to infect the cultures (Fig. 7b). This result suggests
that level of infection of a culture measured as copies of
DNA/mL in supernatant does not necessarily reflect the
infectious potential of that supernatant (i.e. amount of in-
fectious virus). Overall, TCID50/mL calculated using the
size-based method is an easily obtained and reliable tool
to normalize virus stocks for infection cultures.
Discussion
This paper reports the development and evaluation of
an assay useful for day-to-day follow-up of HHV-6B in-
fections in-vitro. It was demonstrated that the cytopathic
effect observed in HHV-6B infections (occurrence of en-
larged cells) can be measured using an imaging-based
automated cell counter, which provides systematic and
objective measurements of the size of cells in the cul-
tures. As the occurrence of enlarged cells was associated
to productive infections in this particular system, this
method provides an objective, fair, and fast way to moni-
tor infections. The cell counter measures the diameters
of cells identified in 8 different fields of a slide, providing
the count of live and dead cells and their sizes, as well
as processed data like cell density, average cell size and
cell viability. The dynamic range for the average size of
cultures was relatively narrow, with the settings of the
counter selected for counting individual cells of up to
50 μm; conveniently, this parameter can be easily ad-
justed which broaden the applicability to other systems.
Results obtained from testing the method in the T
lymphoblast cell line SupT1, susceptible to infection by
HHV-6B strain Z29, indicate that it can indeed be used
to differentiate non-infected and infected cells and cul-
tures. However, analysis of the size of individual cells
showed some overlap between distributions of non-
infected and infected populations. It is possible that, as a
result of a non-synchronic infection of cells, the fraction
of cells that were not infected, or which were not yet
displaying cytopathic effect, might account for some de-
gree of this overlap; this implies at least two populations
coexisting in the same culture. In addition, non-infected
Table 2 TCID50 of HHV-6B Z29 stocks by end-point dilution
assay, using size measurements as read-out
Stock Id TCID50/mL by
average sizea
Virus DNAb
(copies/mL)
s75 45 3.0E + 08
s77 3 3.5E + 08
s78n 34 1.2E + 09
s81 447 2.5E + 09
s83 141 4.9E + 09
s84 447 2.5E + 09
s88 141 1.9E + 09
s100 50 1.8E + 09
s102 159 7.5E + 08
s106 45 2.0E + 09
s111 58 4.4E + 09
s112 20 1.1E + 09
aTCID50/mL calculated using Reed-Muench method [30] and average size of cells
as a read-out. bConcentration of virus DNA in the virus stock measured by qPCR
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cells undergo slight variations in size, likely related to
the cell-cycle stage, also contributing to the overlap, al-
though to a lesser degree. The overlap is greatly reduced
when the average size of cells is used for the analysis ra-
ther than the distribution individual cell sizes. At the
times studied (4 and 7 dpi) enlarged cells are likely pre-
dominant, driving the average to higher values and redu-
cing the overlap. Indeed, there were minimal doses of
virus and minimal times post-infection before which the
infected cultures could not be assessed by the method. It
is possible that under conditions of low virus input,
non-infected and relatively fast-dividing cells outnum-
bered the few infected cells initially generated, resulting
few enlarged cells and neglectable changes in overall
average size of the cells. Low amounts of virus produced
under these conditions would not generate enough in-
fected cells to induce a measurable shift in the popula-
tion’ size distribution. Likewise, at earlier time-points,
the increase in average size and/or the number of en-
larged cells might not be big enough to generate a sig-
nificant shift in the population’ size distribution. As
infections progress, the proportion of infected cells and
the actual size of these cells would have increased
enough to significantly shift the average size of the cells.
A ROC statistical analysis was used to define a prac-
tical cutoff value for deciding whether there was infec-
tion or not. The performance of the method was better
when the average size of cells rather than individual
cells’ size distributions were used. The selection of the
cutoff value was done by maximizing the product speci-
ficity and sensitivity and considering how much loss of
specificity (how many false positives) or loss in sensitiv-
ity (how many false negatives) can be tolerated. Note
that these depend on the particular aim of an experi-
ment. The consensus cutoff values selected for the ana-
lysis involving average size of cells were associated with
4% or less false negatives and false positives, which was
considered appropriate. In the case of monitoring pro-
duction of virus stocks for example, not reaching 100%
sensitivity might be acceptable, as infected cultures that
cannot be clearly differentiated from the non-infected
cultures are likely to represent low-level infections, and
resulting virus stocks likely to contain low amount of
virus. In the case of measuring the infectivity of a virus
stock, both the highest specificity and sensitivity are de-
sirable, because wrong assignment of positive or negative
wells would affect the determination. The performance
of the method when individual size of cells was used was
not as good as for average size of the population, which
might be a reflection of the nature of system (inherent
size variation in non-infected cells and non-synchronic
infections) resulting in a mix of cells at different states.
The cutoff values selected when using individual size of
cells were associated with higher percentages of false
negatives (23-34%), which indicates that cells below the
cutoff value might be wrongly assigned as not infected.
This is consistent with the results of the linear regres-
sion analysis, in which only 51% the data on antigen ex-
pression in cells was explained by the percentage of cells
above the cutoff.
The size-based method described here was particularly
useful when characterizing medium and high level infec-
tions; unfortunately, low-level infections did not gener-
ate enough enlarged cells such that the shift in the size
distribution could not be differentiated by this method.
For instance, in procedures such as generation of
a
b
Fig. 7 Normalization of the dose of virus in different virus stocks. Correlation of dose of virus calculated using TCID50/cell (a) or copies of DNA
per cell (b) and parameters used to estimate infection of the resulting culture (average size, DNA in supernatant (copies/mL) and percentage of
gB positive cells (Pct gB+ cells). Pearson’s correlation coefficients and statistical significance levels are shown
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infectious virus stocks or production of infected cells
(for preparation of total cell lysates for protein analyses,
gene expression assays, etc.), the size-based method can
be used to follow the infections. In these cases, inability
of detect low-level infections does not reduce the practi-
cality of the method, given that low-level infections do
not result in good stocks able to further propagate the
virus nor in highly infected cell preparations, where any
change in gene or protein expression in infected cells
would not be masked by the expression in the predom-
inant non-infected cells.
The analyses and cutoff values described in this work
were obtained using the system of SupT1 cells and
HHV-6B strain Z29 virus. Other cell lines and virus,
such as SupT1.CIITA [23], MOLT-3 and Jurkat E6 in-
fected with HHV-6B strain Z29 and HSB-2 cells infected
with HHV-6A strain GS, also showed measurable oc-
currence of enlarged cells, which should make them
suitable for analysis by this method. However, differ-
ent combinations of cell types and virus strains have
specific characteristics. Basal (non-infected) size dis-
tributions were different for the different cell lines, as
were infection susceptibilities. Thus, each combination
of cell and virus need to be individually standardized.
In setting up the assays, some factors discussed above
should be considered to successfully differentiate non-
infected and infected cultures, in particular the time
after infection when data is collected, the initial
amount of virus used for infection and confirmation
of a productive infection. HHV-6 is known to infect
many cells type with infection progressing to different
endpoints in different cells and with different degrees
of viral production [26]. It is possible that certain cell
types might be infected by HHV-6B without exhibit-
ing cytopathic effects or size increases upon infection.
The method described here would not be appropriate
for such situations.
Another interesting observation was the capacity of the
size-based method to measure the effect of various
methods of virus inactivation. It is known that heat and
UV-inactivation have an effect in the infectivity of HHV-6,
interfering with processes that require the establishment
of a productive infection, as shown by greatly reduced
antigen expression and cytopathic effect [32, 33]. How-
ever, these inactivation methods do not eliminate the abil-
ity of the virus to induce other processes, for example
cytokine and chemokine secretion [34, 35], suggesting that
stable components of the virion are preserved and can still
be taken up by cells and exert effects. Under the con-
ditions employed in our experiments, there was a signifi-
cant reduction of the amount of infectious virus after
inactivation; although not complete, it was enough to re-
sult in low-level infections, which did not induce changes
in the average size. Bearing this in mind, the size-base
method potentially could be used as a first screening tool
to test antiviral methods.
In our work, we used a particular microscope-based
imaging cell counting system but, in principle, the size-
based method would not be restricted to imaging instru-
ments and other counting methods should work as well.
Flow-based cell counters, like Coulter counters and flow
cytometers, also collect size-based data, and potentially
could also be used for this type of analysis. In a flow cyt-
ometer for example, the forward scatter data (FSA)
could be used for quantitative size-based assessment of
infections. A preliminary assessment of this method
showed a shift in the population of infected cells, as ob-
served in FSA histograms (Additional file 4). However,
we observed that it was important to carefully and con-
sistently select the voltages to ensure that most of the
population of infected cells is included in the analysis
and to allow comparisons among measurements per-
formed at different days. A second important point to
consider in the use of a flow-based cytometer in evalu-
ation of infection-induced size increases is the increased
susceptibility of giant cells to fragmentation, which has
been noted in a previous study [36]. In that report, re-
searchers used a Coulter counter, and found that, en-
larged cells that they could identify by visual inspection
using a microscope could not be seen in the size histo-
gram obtained by the Coulter counter, leading them to
suggest that the big refractile infected cells had been
fragmented during the process [36]. In this regard, a
non-flow imaging cell counter such as the one use in
our work reported here, has the advantage that the sam-
ple manipulation is minimal, favoring the preservation
of the bigger cells to a certain degree.
In comparisons of measurements of average size with
measurements of the amount of virus DNA in super-
natant or the expression of viral antigens in cells, similar
trends were observed, suggesting that all methods depict
the same phenomenon in a similar way. This corrobo-
rates that the average cell size-based method is a valid
method to follow HHV-6B infections; it has the advan-
tage of being simple, fast, and providing an objective
measurable result, all of which can be important when
rapid decision is required.
Of the methods that we evaluated, the qPCR-based
method was the most sensitive, allowing detection of 8
± 2 copies of DNA in a single reaction, with a dynamic
range between ~104 to ~1011 copies of DNA per mL.
This allowed detection of small increases in the amount
of virus DNA produced when lower amounts of virus
were used to infect the cells and/or when earlier times
were analyzed. In fact, qPCR method could detect
amounts of virus that did not induce measurable shifts
in the average size of the cell cultures, consistent with
low-level infections. However, this method can be used
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only for populations of cells, not for evaluation of infec-
tion on a cell-by-cell basis.
The flow cytometry method using fluorescence detec-
tion of viral antigens has the advantage of providing the
frequency of cells expressing that viral antigen within
the whole population, which is an important metric
when studying viral infections in-vitro. Infected cells
could be identified by flow cytometry when relatively
low doses of virus and early time points were analyzed,
even after accounting for non-specific binding of anti-
bodies to non-infected cells, and by the increased auto-
fluorescence of infected cells. A drawback of this
method is that infected cells might be mistakenly ex-
cluded from the analysis as a result of several factors
including the acquisition voltages and gating strategies
excluding the largest cells, uptake of viability dyes by
dying infected cells, or increased fragility of larger cells.
These factors could be especially important when col-
lecting data at longer time points after infection when
the viability of the cells has decreased and when there
is a high proportion of larger cells. We seem to have
observed this effect in Fig. 2d and e, where infections
performed with the highest concentration of virus ex-
hibited reduced gB expression at 7 dpi relative to 4 dpi,
whereas the other markers of infection (size, cell death,
and viral DNA copies) all increase during this time
period. This might be the result of the largest and/or
most fragile cells being excluded from the analysis.
Finally, besides monitoring infections, the method was
used to determine the relative infectivity of virus stocks.
In the end-point assay, the average size method per-
formed well in differentiating among dilutions. However,
the fact that low-level infections do not induce signifi-
cant changes in the average size could lead to underesti-
mation of viral titers, especially compared to more
sensitive methods like qPCR and flow cytometry. In spite
of this, in terms of infectivity, the size-based TCID50
provided better equivalence among virus stocks than
copies of viral DNA.
Conclusions
A method is presented to evaluate HHV-6B infection of
cell cultures using individual and average measurements
of cell size obtained with an imaging-based automated
cell counter. Overall, the reciprocity observed in the
trends between average size, level of virus DNA in
supernatant, and expression of viral antigens in cells,
suggests that measurement of average cell size is a suit-
able method to follow a productive HHV-6B infection,
particularly at higher doses of virus and/or longer times
post-infection. The method may prove useful for a rapid
initial assessment of infected cultures with the advantage
of generating almost immediate results.
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